• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Glaucoma Surgery Market

    ID: MRFR/MED/17433-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Glaucoma Surgery Market Research Report By Target (Trabecular meshwork, Suprachoroidal space, Others), By Type of surgery (Angle closure glaucoma surgery, Aqueous shunt surgery, laser surgery, Others) and By End User (Hospital, Ambulatory surgery centers, Others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Glaucoma Surgery Market Infographic
    Purchase Options

    US Glaucoma Surgery Market Summary

    The US Glaucoma Surgery market is projected to grow significantly from 178.8 million USD in 2024 to 366.1 million USD by 2035.

    Key Market Trends & Highlights

    US Glaucoma Surgery Key Trends and Highlights

    • The US Glaucoma Surgery market is valued at 178.8 million USD in 2024.
    • By 2035, the market is expected to reach 366.1 million USD, indicating robust growth.
    • The compound annual growth rate (CAGR) is projected at 6.73% from 2025 to 2035.
    • Growing adoption of advanced surgical techniques due to increasing prevalence of glaucoma is a major market driver.

    Market Size & Forecast

    2024 Market Size 178.8 (USD Million)
    2035 Market Size 366.1 (USD Million)
    CAGR (2025-2035) 6.73%

    Major Players

    IRIDEX, Aerie Pharmaceuticals, Novartis, Santen Pharmaceutical, Bausch Health, Ocular Therapeutix, Alcon, Carl Zeiss AG, AbbVie, Glaukos, Lumenis, AngioDynamics, Johnson and Johnson, Heidelberg Engineering, Surround Health

    US Glaucoma Surgery Market Trends

    The US glaucoma surgery market is currently witnessing notable trends driven by the rising prevalence of glaucoma and an aging population. With a significant portion of the American population affected by this eye condition, the demand for surgical interventions is increasing.

    Technological advancements in surgical techniques, such as minimally invasive glaucoma surgeries (MIGS), play a critical role in enhancing treatment outcomes and patient satisfaction. These newer surgical options provide patients with less trauma, quicker recovery times, and fewer complications compared to traditional procedures, aligning with the growing preference for outpatient services.

    Opportunities to be captured in this market include the expansion of patient education and awareness campaigns. Many individuals remain unaware of their risk for glaucoma and the available surgical options. By enhancing education around the importance of regular eye examinations and the role of surgery in glaucoma management, healthcare providers can encourage early diagnosis and treatment, thus opening doors for more effective care pathways.

    Trends over recent years also indicate an increasing focus on personalized medicine, with treatments becoming more tailored to individual patient needs. This shift requires healthcare providers to adapt their practices and embrace innovative technologies.

    Moreover, collaborations among ophthalmic device manufacturers and healthcare systems are gaining attention, driving the development of new products that meet specific patient requirements. The ongoing research into the genetic factors associated with glaucoma is further expected to influence treatment approaches, ensuring that the US market continues to evolve to meet the pressing needs of glaucoma patients effectively.

    Market Segment Insights

    Glaucoma Surgery Market Target Insights

    The US Glaucoma Surgery Market demonstrates significant potential for growth, especially within its distinct market segmentation that includes various techniques and methodologies. The Trabecular meshwork segment, known for its critical role in facilitating intraocular fluid drainage, holds a substantial position in the overall market dynamics.

    Advances in surgical procedures focusing on the Trabecular meshwork are paramount due to their ability to provide effective and minimally invasive solutions for patients suffering from glaucoma, addressing a critical need in the US where glaucoma is a leading cause of irreversible blindness.

    Furthermore, the Suprachoroidal space segment is emerging as an innovative approach in glaucoma surgery, offering the opportunity to target specific anatomical areas of the eye to enhance surgical outcomes. This emerging technique is drawing attention due to its potential to minimize complications and improve post-operative recovery, which is crucial given the aging population in the US that increasingly suffers from various ocular diseases.

    Alongside these segments, other methodologies continue to gain traction, reflecting the industry's adaptability and responsiveness to patient needs. The diversity in the US Glaucoma Surgery Market segmentation allows for comprehensive treatment options, catering to various glaucoma types and stages.

    The combination of research advancements and expanding procedure offerings contributes to the overall market growth and the enhancement of patient care within this serious health issue. With the increasing prevalence of glaucoma and the growing awareness among patients and healthcare professionals about the importance of timely intervention, the US Glaucoma Surgery Market is witnessing considerable attention and investment.

    Glaucoma Surgery Market Type of surgery Insights

    The US Glaucoma Surgery Market showcases a diversified approach to treating various forms of glaucoma, with the Type of surgery segment playing a critical role in addressing patient needs. Angle closure glaucoma surgery is particularly significant due to its urgent nature, often requiring immediate intervention to prevent vision loss.

    Similarly, aqueous shunt surgery is important because it effectively alleviates intraocular pressure by providing a controlled pathway for aqueous humor drainage, thus helping patients with chronic forms of glaucoma. Laser surgery stands out as a technologically advanced method, gaining popularity for its minimally invasive techniques and quicker recovery times, making it a preferred option for many patients.

    The 'Others' category encapsulates a range of surgical innovations and alternative treatments, reflecting the dynamic nature of the US Glaucoma Surgery Market. Collectively, these types underscore the importance of personalized treatment plans, which are increasingly tailored to individual patient profiles and glaucoma types, ensuring enhanced patient outcomes and compliance with evolving healthcare standards in the US.

    As research and development continue to advance these surgical options, the US market is poised for growth in an effort to meet the needs of an ageing population, where glaucoma prevalence continues to rise.

    Glaucoma Surgery Market End User Insights

    The US Glaucoma Surgery Market's End User segment is primarily composed of Hospitals, Ambulatory Surgery Centers, and other facilities that provide surgical interventions for glaucoma. Hospitals typically dominate this area due to their comprehensive resources, experienced medical staff, and expansive patient reach, enabling them to perform complex procedures more effectively.

    Ambulatory Surgery Centers are gaining traction as they offer a more efficient, cost-effective environment for glaucoma surgeries, appealing to both healthcare providers and patients looking for quicker recovery times. The growing prevalence of glaucoma and advancements in minimally invasive surgical techniques are major drivers of this market's expansion.

    Additionally, the increasing awareness of eye health in the US is contributing to a rising patient base seeking surgical solutions. The segment is influenced by the aging population, as glaucoma is more common in older adults, leading to a sustained demand for surgical interventions.

    Overall, the US Glaucoma Surgery Market Exhibits a promising trajectory with significant growth potential, as new technologies emerge and healthcare facilities continue to adapt to patient needs.

    Get more detailed insights about US Glaucoma Surgery Market

    Key Players and Competitive Insights

    The US Glaucoma Surgery Market exhibits a dynamic landscape characterized by ongoing advancements in surgical techniques, devices, and healthcare practices aimed at improving patient outcomes. Competitive insights in this market reflect the heightened focus on innovative treatment solutions that cater to the increasing prevalence of glaucoma, particularly among the aging population.

    As the market evolves, various companies are vying for a significant share, leading to substantial investments in research and development, as well as strategic partnerships and alliances that enhance their market positions and capabilities. The competition is shaped not only by the effectiveness and safety of surgical interventions but also by the ability to navigate regulatory pathways and fulfill the unique needs of patients and healthcare providers.

    IRIDEX has established a strong presence in the US Glaucoma Surgery Market through its focused strategy on developing minimally invasive surgical technologies. With an emphasis on laser-based solutions, IRIDEX has carved a niche with its effective offerings that are designed to provide reliable and efficient treatment options for glaucoma patients.

    The company leverages its proprietary technologies and robust clinical evidence to differentiate its product range in a crowded marketplace. Strengths lie in its extensive expertise in ophthalmic lasers and its commitment to innovation, which fosters trust among healthcare professionals and patients alike.

    Through strategic collaborations and ongoing investments, IRIDEX continues to enhance its capabilities in the US market, ensuring its relevance and competitive edge in this vital sector.

    Aerie Pharmaceuticals has made significant strides within the US Glaucoma Surgery Market, particularly known for its commitment to developing innovative therapies aimed at lowering intraocular pressure in patients with glaucoma. The company's key products include a range of medicines that utilize novel mechanisms of action and address various patient needs.

    Aerie Pharmaceuticals has established a commendable market presence, bolstered by successful clinical trials that underline the efficacy and safety of its portfolio. The company's strengths lie in its focused research initiatives and dedication to advancing treatment options.

    Additionally, Aerie's strategic mergers and acquisitions have further expanded its capabilities, enabling access to new technologies and expertise that enhance its product offerings in the US. With a strong emphasis on patient-centric solutions and a commitment to addressing unmet needs in glaucoma treatment, Aerie Pharmaceuticals is poised for continued growth and impact in the market.

    Key Companies in the US Glaucoma Surgery Market market include

    Industry Developments

    Recent developments in the US Glaucoma Surgery Market have shown significant activity among key players. Companies such as Alcon and Glaukos have advanced their Research and Development initiatives to innovate new surgical techniques and devices aimed at improving patient outcomes.

    Aerie Pharmaceuticals has reported growth in its product pipeline, while Novartis continues to expand its therapeutic options for managing glaucoma. In terms of mergers and acquisitions, Santen Pharmaceutical announced the acquisition of a portfolio of assets from a private firm in September 2023, which is expected to bolster its presence in the US market.

    Additionally, Bausch Health has made strategic investments to enhance its product offerings, reinforcing its position in the competitive landscape. The heightened focus on minimally invasive surgical options is driving industry growth, as patient demand for less invasive procedures increases.

    In the past two years, the industry has witnessed substantial funding allocated towards technological advancements and collaborations among major companies like Johnson and Johnson and Heidelberg Engineering, influencing the market dynamics.

    Overall, the US Glaucoma Surgery Market is experiencing a robust expansion, underpinned by continuous innovation and strategic alignments among leading firms.

    Market Segmentation

    Glaucoma Surgery Market Target Outlook

    • Trabecular meshwork
    • Suprachoroidal space
    • Others

    Glaucoma Surgery Market End User Outlook

    • Hospital
    • Ambulatory surgery centers
    • Others

    Glaucoma Surgery Market Type of surgery Outlook

    • Angle closure glaucoma surgery
    • Aqueous shunt surgery
    • laser surgery
    • Others

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 167.59(USD Million)
    MARKET SIZE 2024 178.85(USD Million)
    MARKET SIZE 2035 366.05(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.728% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED IRIDEX, Aerie Pharmaceuticals, Novartis, Santen Pharmaceutical, Bausch Health, Ocular Therapeutix, Alcon, Carl Zeiss AG, AbbVie, Glaukos, Lumenis, AngioDynamics, Johnson and Johnson, Heidelberg Engineering, Surround Health
    SEGMENTS COVERED Target, Type of surgery, End User
    KEY MARKET OPPORTUNITIES Minimally invasive surgical techniques, Advanced imaging technologies, Increased aging population, Rising prevalence of glaucoma, Growing awareness and education initiatives
    KEY MARKET DYNAMICS Aging population, Increasing prevalence of glaucoma, Technological advancements in surgery, Rising healthcare expenditure, Growing awareness and education
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Glaucoma Surgery Market in 2024?

    The US Glaucoma Surgery Market is expected to be valued at 178.85 million USD in 2024.

    What will be the projected market size of the US Glaucoma Surgery Market by 2035?

    By 2035, the US Glaucoma Surgery Market is projected to reach 366.05 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Glaucoma Surgery Market from 2025 to 2035?

    The expected CAGR for the US Glaucoma Surgery Market from 2025 to 2035 is 6.728%.

    Which sub-segment of the US Glaucoma Surgery Market is expected to have the largest value in 2024?

    The Trabecular meshwork sub-segment is expected to hold the largest value at 70.0 million USD in 2024.

    What will be the market size for the Suprachoroidal space sub-segment by 2035?

    The Suprachoroidal space sub-segment is expected to reach a market size of 120.0 million USD by 2035.

    Who are the key players in the US Glaucoma Surgery Market?

    Key players in the US Glaucoma Surgery Market include IRIDEX, Aerie Pharmaceuticals, Novartis, and Glaukos.

    What is the expected value for the 'Others' sub-segment of the US Glaucoma Surgery Market in 2035?

    'Others' sub-segment is projected to be valued at 96.05 million USD by 2035.

    How does the US Glaucoma Surgery Market growth rate vary across regions?

    The US Glaucoma Surgery Market is primarily driven by advancements in technology across the country.

    What are some emerging trends in the US Glaucoma Surgery Market?

    Emerging trends include increasing patient awareness and advancements in surgical techniques.

    What challenges are currently facing the US Glaucoma Surgery Market?

    Regulatory challenges and high treatment costs are significant challenges faced in the US Glaucoma Surgery Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials